Conference
Phase II study of oral ENMD-2076 administered to patients with ovarian clear cell carcinoma: A trial of the Princess Margaret Phase II Consortium.
Authors
Martin-Lorente C; Tan DS; Dhani N; Butler M; Mackay H; Wilson M; Lheureux S; Hirte HW; Welch S; Weberpals JI
Volume
32
Pagination
pp. tps5620-tps5620
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.tps5620
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X